Verona Pharma Plc (VRNA) Directors and Executive Officers - CSIMarket
CSIMarket
 
Verona Pharma Plc  (NASDAQ: VRNA)

Verona Pharma Plc

Officers & Directors


Christina Ackermann
Director

Mark W. Hahn
Chief Financial Officer (principal financial and accounting officer)

Michael Austwick
Director

Martin Edwards, M.D.
Director

Mahendra Shah, Ph.D.
Director


Reading, United Kingdom

Ken Cunningham, M.D.
Director

David Zaccardelli
President and Chief Executive Officer (principal executive officer)

Vikas Sinha
Director

Anders Ullman, M.D., Ph.D.
Director

David Ebsworth, Ph.D.
Chairperson of the Board of Directors

David Zaccardelli, Pharm. D.
President and Chief Executive Officer

Lisa Deschamps
Director

James Brady
Director ,

Verona Pharma Plc currently has 79 employees.

  News about Verona Pharma Plc Key Personnel

Verona Pharma Bolsters Leadership with Appointment of Andrew Fisher as General Counsel amid Financial Challenges







VRNA Management Effectiveness VRNA Revenue per Employee VRNA Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.